Johnson & JohnsonJNJ
$663.3B market capJohnson & JohnsonJNJRevenue: is the business selling more than it used to?
$94.2B+6% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $94.2B in 2025, compounding +2% a year since 2019 and the pace is picking up. The trailing twelve months are already running at $97.9B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJNet income: how much of that revenue becomes profit?
$26.8B+91% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $26.8B in 2025, compounding +10% a year over three years. Trailing twelve-month profit stands at $21.0B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJHow fast is it growing, year by year?
+6.0%revenue growth, FY 2025
Off the axis: 2018 earnings +1076.7% - rebounds off a collapsed prior year.
→Revenue grew +6% in 2025 against a five-year average of +4%. Earnings grew faster (+91%), so each new dollar of sales is arriving more profitably. 2018's +1077% earnings rebound off a collapsed base sits off the axis.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJRevenue per share: is your slice growing as fast as the company?
$38.77revenue per share, FY 2025
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-28), not a full fiscal year
→Revenue per share reached $38.77 in 2025, compounding +4% a year against +2% for JNJ as a whole. Buybacks added roughly 1.7 points to your per-share result. Free cash flow per share stands at $8.11.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJFree cash flow: what is left in real cash after everything?
$19.7B−1% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow was $19.7B in 2025, compounding -0% a year since 2019. The trailing twelve months stand at $22.2B.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJHow much of every sales dollar ends up as free cash?
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→21 cents of every sales dollar became free cash in 2025, and it has held steady since 2023.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJWhat does staying competitive cost, per dollar of sales?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-28), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 5% of revenue (stock compensation 1%, research and development 0%). That share has risen since 2019, so the cost of competing is climbing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJMargins: of every $1 of sales, how much survives each cost layer?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-28), not a full fiscal year
→Net margin stands at 28% in 2025. JNJ doesn't break out gross or operating margin in its filings, so net is the only layer the data supports.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJWhat does it earn on the money it uses?
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-28), not a full fiscal year
→JNJ earns 25% on shareholders' capital. Return on capital employed isn't meaningful for this business model, so ROE carries the picture alone.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJWhat has the market paid for JNJ over time?
31.8xP/E today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 31.8x earnings, the market is paying +62% more than JNJ's own 6-year median of 19.6x. Expectations are elevated, so more has to go right to justify the price.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJWhat cash return does the business throw off per dollar of market value?
3.4%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 3.4% of annual free cash flow, less than its 6-year median of 6.4% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJCould it handle its debt if things went wrong?
→Debt of $49.0B sits against $20.4B of cash, or 0.6x shareholders' equity. Earnings cover the interest bill 22 times over, so the debt is comfortably serviced.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJIs the company's own capital growing?
→The company's own capital grew from $68.8B in 2023 to $85.0B (+24%). The business is building book value rather than consuming it.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJHow much goes back, and how much leaks out as stock comp?
→Shareholders received $6.0B in buybacks in 2025. Stock compensation issued $1.4B of new shares in the same year, offsetting 23% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJHow fast is your ownership being diluted - or concentrated?
→The share count shrank 0.0% in 2025, averaging 3.2% a year over three years. Buybacks are concentrating your ownership: the same business, split fewer ways.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJJNJ has issued or retired shares - did shareholders end up better off?
→JNJ has shrunk its share count -17% from 2007 to 2025, so each remaining share owns more of the business. Revenue per share is +85% over the same years.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28
Johnson & JohnsonJNJAre the people running it buying or selling?
→Insiders sold $129M on the open market and bought nothing. Many sales are pre-scheduled diversification rather than a view on the price. A further 36 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-28